TipRanks

Notifications

Tag: ALGN

Total 149 Posts

Stifel העלו את מחיר היעד שלהם עבור Align Technology ל-350 דולר, מהמחיר הקודם של 340 דולר, וממשיכים להמליץ על רכישת המניה

הפירמה חושבת שלמרות שמחיר המניה של Align עלה מתחילת השנה, היא עדיין מציעה אחת ההזדמנויות הטובות ביותר לרווח בהשוואה לחברות אחרות שהם עוקבים אחריהן, לפי האנליסט.

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), Align Tech (ALGN) and Jazz Pharmaceuticals (JAZZ)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Intuitive Surgical (ISRGResearch Report), Align Tech (ALGNResearch Report) and Jazz Pharmaceuticals (JAZZResearch Report) with bullish sentiments.

Intuitive Surgical (ISRG)

In a report released today, Rick Wise from Stifel Nicolaus maintained a Buy rating on Intuitive Surgical, with a price target of $420.00. The company’s shares closed last Thursday at $384.31, close to its 52-week high of $403.00.

According to TipRanks.com, Wise is a 4-star analyst with an average return of 4.8% and a 58.4% success rate. Wise covers the Healthcare sector, focusing on stocks such as Treace Medical Concepts, Baxter International, and Edwards Lifesciences.

Currently, the analyst consensus on Intuitive Surgical is a Moderate Buy with an average price target of $415.82, implying an 8.5% upside from current levels. In a report released today, Piper Sandler also reiterated a Buy rating on the stock with a $425.00 price target.

See today’s best-performing stocks on TipRanks >>

Align Tech (ALGN)

In a report released today, Jonathan Block from Stifel Nicolaus maintained a Buy rating on Align Tech, with a price target of $350.00. The company’s shares closed last Thursday at $316.92.

According to TipRanks.com, Block is a 5-star analyst with an average return of 9.8% and a 53.3% success rate. Block covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Elanco Animal Health, and Patterson Companies.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Align Tech with a $301.44 average price target, implying a -6.5% downside from current levels. In a report issued on March 13, Piper Sandler also reiterated a Buy rating on the stock with a $355.00 price target.

Jazz Pharmaceuticals (JAZZ)

In a report released today, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Jazz Pharmaceuticals, with a price target of $230.00. The company’s shares closed last Thursday at $118.30.

According to TipRanks.com, Samimy is a 4-star analyst with an average return of 10.9% and a 48.0% success rate. Samimy covers the Healthcare sector, focusing on stocks such as Calliditas Therapeutics, Apellis Pharmaceuticals, and Revance Therapeutics.

Jazz Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $185.34, representing a 57.7% upside. In a report issued on February 29, Needham also maintained a Buy rating on the stock with a $220.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ISRG:

Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Legend Biotech (LEGN) and Aslan Pharmaceuticals (ASLN)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Align Tech (ALGNResearch Report), Legend Biotech (LEGNResearch Report) and Aslan Pharmaceuticals (ASLNResearch Report) with bullish sentiments.

Align Tech (ALGN)

Piper Sandler analyst Jason Bednar reiterated a Buy rating on Align Tech today and set a price target of $355.00. The company’s shares closed last Tuesday at $310.68.

According to TipRanks.com, Bednar ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -4.5% and a 40.8% success rate. Bednar covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Merit Medical Systems, and Alpha Tau Medical Ltd.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Align Tech with a $300.33 average price target.

See Insiders’ Hot Stocks on TipRanks >>

Legend Biotech (LEGN)

In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Legend Biotech, with a price target of $87.00. The company’s shares closed last Tuesday at $65.13.

According to TipRanks.com, Kapoor has 0 stars on 0-5 stars ranking scale with an average return of -6.6% and a 40.2% success rate. Kapoor covers the Healthcare sector, focusing on stocks such as Cartesian Therapeutics, Reneo Pharmaceuticals, and Carisma Therapeutics.

Currently, the analyst consensus on Legend Biotech is a Strong Buy with an average price target of $87.36, which is a 34.9% upside from current levels. In a report released yesterday, J.P. Morgan also maintained a Buy rating on the stock with a $80.00 price target.

Aslan Pharmaceuticals (ASLN)

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Aslan Pharmaceuticals, with a price target of $10.00. The company’s shares closed last Tuesday at $0.69, close to its 52-week low of $0.39.

According to TipRanks.com, Tenthoff is a 4-star analyst with an average return of 5.0% and a 38.5% success rate. Tenthoff covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, Milestone Pharmaceuticals, and Arvinas Holding Company.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Aslan Pharmaceuticals with a $10.00 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ALGN: